ID: ALA179290

Max Phase: Preclinical

Molecular Formula: C25H27N3O3

Molecular Weight: 417.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCN1C(=O)c2cc(NC(=O)C(C)(C)C)cc3cc4ccccc4c(c23)C1=O

Standard InChI:  InChI=1S/C25H27N3O3/c1-25(2,3)24(31)26-17-13-16-12-15-8-6-7-9-18(15)21-20(16)19(14-17)22(29)28(23(21)30)11-10-27(4)5/h6-9,12-14H,10-11H2,1-5H3,(H,26,31)

Standard InChI Key:  URHORUSQPATJLJ-UHFFFAOYSA-N

Associated Targets(Human)

UACC-375 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

OVCAR-3 48710 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 417.51Molecular Weight (Monoisotopic): 417.2052AlogP: 4.14#Rotatable Bonds: 4
Polar Surface Area: 69.72Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.42CX Basic pKa: 8.52CX LogP: 3.95CX LogD: 2.80
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.88

References

1. Sami SM, Dorr RT, Sólyom AM, Alberts DS, Remers WA..  (1995)  Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.,  38  (6): [PMID:7699715] [10.1021/jm00006a018]

Source